Fiera Capital (Canada)
ABMD

Fiera Capital (Canada)’s Abiomed Inc ABMD Stock Holding History

Fiera Capital (Canada)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,655
Closed -$527K – 596
2021
Q1 		$527K Buy
1,655
+155
+10% +$49.6K ﹤0.01% 473
2020
Q4 		$486K Buy
+1,500
New +$415K ﹤0.01% 531
2016
Q4 		– Sell
-67,937
Closed -$8.73M – 813
2016
Q3 		$8.73M Sell
67,937
-59,834
-47% -$7.17M 0.05% 259
2016
Q2 		$14M Buy
+127,771
New +$12.7M 0.08% 210

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fiera Capital (Canada)'s ABMD Position: Q2 2021 in Review

Fiera Capital (Canada) sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 1,655 shares — an estimated $527K sold.

Fiera Capital (Canada) first reported a position in ABMD in Q2 2016 and held it in 4 quarters. The position peaked at $14M in Q2 2016. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Fiera Capital (Canada) reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,655 Abiomed Inc shares in Q2 2021, an estimated $527K.
  • Fiera Capital (Canada) first reported a position in Abiomed Inc in Q2 2016 and held it in 4 quarters.
  • Fiera Capital (Canada)'s Abiomed Inc position peaked at $14M in Q2 2016.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2021, filed 11 Aug 2021.